
1 - 10 employees
Founded 2017
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° $100M Private Equity Round on 2022-04
Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
đź•’ May 26
Improve your chances of getting an interview by checking your resume score before you apply.

1 - 10 employees
Founded 2017
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° $100M Private Equity Round on 2022-04
Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
• Lead formulation development strategy for a new bispecific fusion protein from preclinical stage through clinical development. • Design and execute studies to assess protein stability, aggregation, degradation pathways, viscosity, and developability under relevant formulation conditions. • Develop liquid and, where appropriate, lyophilized formulations to support both IV and SC presentations. • Lead excipient screening, buffer optimization, pH optimization, surfactant selection, and stress stability studies to identify robust drug product formulations. • Drive high-concentration formulation development for subcutaneous delivery, including syringeability, injectability, and device compatibility assessments. • Partner closely with Analytical Development to establish appropriate characterization methods for formulation screening, stability assessment, and comparability studies. • Collaborate with Drug Substance, Process Development, Quality, Regulatory, Clinical Supply, and external CDMOs to ensure alignment between formulation strategy, manufacturability, and clinical needs. • Provide technical leadership for drug product process development, fill-finish considerations, container closure selection, and tech transfer activities. • Serve as the formulation subject matter expert during regulatory interactions and contribute to CMC sections of regulatory filings, including IND, IMPD, and BLA submissions. • Identify formulation-related risks early and develop mitigation strategies to support program timelines and long-term product quality. • Evaluate and implement new technologies and platform approaches to improve formulation development capabilities for complex biologics.
• Ph.D. in Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biochemistry, or a related field with 8+ years of relevant industry experience; or M.S. with 10+ years of relevant experience. • Deep expertise in formulation development for biologics, including monoclonal antibodies, bispecific antibodies, fusion proteins, or other large-molecule therapeutics. • Strong hands-on experience with protein stability assessment, excipient selection, buffer optimization, and formulation screening for early- and late-stage development. • Demonstrated experience developing formulations for high-concentration biologics and supporting subcutaneous and intravenous presentations. • Familiarity with key challenges associated with complex protein therapeutics, including aggregation, fragmentation, oxidation, deamidation, viscosity, and interfacial instability. • Experience working with external CDMOs and managing outsourced formulation and drug product development activities. • Strong understanding of drug product manufacturing, fill-finish operations, container closure systems, and clinical supply requirements. • Familiarity with regulatory expectations for formulation and drug product development in biologics programs. • Excellent leadership, communication, and project management skills, with the ability to work effectively across multidisciplinary teams. • Prior experience supporting regulatory submissions and health authority interactions is preferred.
• Flexible working arrangements • Professional development opportunities
Apply Nowđź•’ May 24
Senior Director of Product Strategy at PowerSchool guiding go-to-market for analytics products. Leading cross-functional teams in delivering educational solutions.
🇺🇸 United States – Remote
đź’µ $150.7k - $207.2k / year
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
đź•’ May 24
Associate Director for Field Medical Affairs, focusing on Dermatology at Regeneron. Engage with healthcare professionals to deliver scientific information and support research activities.
🇺🇸 United States – Remote
đź’µ $176.1k - $287.3k / year
đź’° Post-IPO Equity on 2023-10
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
đź•’ May 22
Senior Director, Construction overseeing construction activities to support company growth and operational excellence. Collaborating with cross-functional teams and providing leadership and strategic direction.
đź•’ May 22
Drive commercial strategy and program management for AI-powered HCP engagement. Seeking a seasoned leader to partner with the Chief Commercial Officer.
🇺🇸 United States – Remote
đź’µ $170k - $220k / year
đź’° $3M Seed Round on 2022-04
⏰ Full Time
đźź Senior
đź‘” Director
đź•’ May 22
Senior Director of National Accounts for Neurotech Pharmaceuticals, managing market access strategies and leading the Director of National accounts team to improve payer access. Collaborates across functions to enhance brand performance and product launches.